Zymergen ZY 深 沪
等待开盘 09-12 09:30:00 美东时间
2.43
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 2.43
- 总市值 2.53亿
- 52周最高 11.87
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.10
- 委 比 0.00%
- 总股本 1.04亿
- 历史最高 52.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.10
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多STORZ & BICKEL Unveils VEAZY: A New Compact Vaporizer
Canopy Growth ( ($TSE:WEED) ) has issued an update. STORZ & BICKEL, a subsi...
09-10 00:37
Ray Dalio Says Crypto Could Be An 'Attractive Alternative' As Fiat Money Will Struggle As 'Effective Storeholds' Of Wealth
Billionaire hedge fund manager Ray Dalio expressed optimism on Wednesday about the prospect of cryptocurrencies becoming an “attractive alternative” to struggling fiat currencies.
09-05 13:12
港股早知道 | 南向资金年度净买入额超1万亿港元，刷新历史纪录；药明合联拟配股筹资逾13亿港元
南向资金年度净买入额超1万亿港元，刷新历史纪录；药明合联拟配股筹资逾13亿港元；云锋金融斥4400万美元累购1万枚ETH>>
09-03 09:00
Philip Morris International issues profit guidance slightly below expectations
Philip Morris International (NYSE:PM) provided a guidance update ahead of the company's appearance at the Barclays Global Consumer Staples Conference. The tobacco giant reaffirmed its 2025 full-year r...
09-02 21:24
PMI Reaffirms 2025 Full-Year Forecast, Sees Adjusted EPS $7.43-$7.56;, Adj. EPS Excluding Currency $7.33-$7.46
PMI reaffirms its 2025 full-year reported diluted EPS forecast, announced on July 22, 2025, to be in a range of $7.24 to $7.37. Excluding a total 2025 adjustment of $0.19 per share, this forecast represents a projected
09-02 21:09
7点！医械早播报-9/2
（来源：医疗器械创新网） 01 监管政策与招投标 国常会召开，基层器械市场大利好 国常会通过《医疗卫生强基工程实施方案》，加大基层医疗投入，提升县域诊疗能力，推...
09-02 07:00
业绩与股价齐飞，中原内配上演“戴维斯双击”
在汽车行业持续复苏、新能源车大幅增长的背景下，全球气缸套龙头企业中原内配近日交出了一份亮眼的半年报。 数据显示，上半年，中原内配（002448.SZ）实现营业收...
08-29 09:00
Bitcoin And Ethereum's Liquidity-Driven Highs Expose Fragility At All-Time Peaks: Report
Bitcoin (CRYPTO: BTC) and Ethereum's (CRYPTO: ETH) surge highlights how tightly crypto markets have become bound to global liquidity cycles, with central bank signals now moving prices as
08-28 22:47
医疗板块回暖+中报营收利润双高增，归创通桥（2190.HK）凭什么领跑创新械企？
2025年以来，沉寂已久的港股医药行业迎来强势反弹。富途显示，今年恒生医疗保健指数累计涨幅已突破100%，不仅如同一记强心针点燃市场热情，更引发市场对行业走势的...
08-27 11:40
